ClinConnect ClinConnect Logo
Search / Trial NCT04026386

A Center Based Early Intervention Program for Preschoolers with Developmental Disorders

Launched by STANFORD UNIVERSITY · Jul 17, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a 12-week early intervention program designed to help preschoolers with developmental disorders, such as Autism Spectrum Disorder, improve their social communication skills. The program offers 12 hours each week of intensive support either at a specialized preschool or in the child's home. The goal is to see how effective this approach is in helping young children who may have difficulties with communication and social interactions.

To be eligible for the study, children must be between 2 and 5 years old and have a diagnosed developmental disorder like Autism or an intellectual disability. The program is open to all boys and girls who can participate in the activities. However, children with severe psychiatric disorders or those who cannot attend the program during its scheduled hours will not be included. Families who join the study can expect a structured and supportive environment aimed at enhancing their child's communication skills over the course of the trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of Developmental Disorder, such as Autism Spectrum Disorder, neurogenetic disorder, or intellectual disability, based on clinical interview;
  • Boys and girls between 2.0 years and 5.11 years at time of enrollment;
  • Ability to participate in the testing procedures to the extent that valid standard scores can be obtained.
  • Exclusion Criteria:
  • Current or lifetime diagnosis of severe psychiatric disorder (e.g., bipolar disorder, etc.);
  • Lack of availability during program hours.

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Stanford, California, United States

Patients applied

0 patients applied

Trial Officials

Antonio Hardan, MD

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials